Communiqué de presse
Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
U. S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 […]